Low risk localized prostate cancer: no harm from waiting!

ORLANDO, FLORIDA—A decision to delay surgery or radiotherapy for early prostate cancer is in the best interests of most patients according to research presented to the 2013 Genitourinary Cancers Symposium by Dr Andrew Loblaw from the Sunnybrook Health Sciences Centre in Toronto who talked with Peter Goodwin about his group’s finding that the rate of “migration” of Gleason grade — representing the gradual progression of the disease — was gradual, with no more than a third of patients developing a form of the disease requiring treatment within ten years: so the remaining patients can be spared side effects from treatment.

LISTEN

[audio:https://www.audiomedica.com/podcasting/oncology/130310AndrewLoblawAJOPODCASTLoRes.mp3]